Tumor-specific gene expression in hepatic metastases by a replication-activated adenovirus vector

Nature Medicine

Volumn 7, Issue 2, 2001, Pages 240-243

  Steinwaerder, Dirk S ^a   Carlson, Cheryl A ^a,b   Otto, Desiree L ^a   Li, Zong Yi ^a   Ni, Shaoheng ^a   Lieber, André ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; GENE THERAPY; GENETIC RECOMBINATION; LIVER METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; CELL LINE; GENE EXPRESSION; GENES, REPORTER; GENETIC VECTORS; HELA CELLS; HUMANS; LIVER; MICE; MICE, NUDE; VIRUS ACTIVATION; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALIA;

EID: 0035125735     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/84696     Document Type: Article

References (25)

1. Targeting gene therapy to cancer: A review
2. Replicative adenoviruses for cancer therapy
3. Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication
4. Liver-directed gene transfer in non-human primates
5. DNA replication of first-generation adenovirus vectors in tumor cells
6. Generation of adenovirus vectors devoid of all viral genes by recombination between inverted repeals
7. Studies on the mechanism of repliction of adenovirus DNA. I. The effect of hydroxyurea
8. Widespread long-term gene transfer to mouse skeletal muscles and heart
9. Insulation from viral transcriptional regulatory elements impoves inducible transgene expression from adenovirus vectors in vitro and in vivo
10. The hallmarks of cancer
11. An oncolytic herpes simplex virus type 1 selectively destroys diffuse liver metastases from colon carcinoma
12. Highly efficient transduction and expression of cytokine genes in human tumor cells by means of autonomous parvovirus vectors; generation of antitumor responses in recipient mice
13. Reovirus therapy of tumors with activated Ras pathway
14. Development and application of adenoviral vectors for gene therapy of cancer
15. Cellular promoters incorporated into the adenovirus genome: Effects of viral regulatory elements on transcription rates and cell specificity of albumin and beta-globin promoters
16. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents
17. An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
18. Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein
19. A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma
20. Method for multiple portal vein infusions in mice: Quantification of adenovirus mediated hepatic gene transfer
21. Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first- generation vectors in vitro and in vivo
22. Cytokines and growth factors induce HSP27 phosphorylation in human astrocytes
23. Efficient gene transfer into human CD34+ cells by a retargeted adenovirus vector
24. DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors
25. Collagenase pretreatment and the mitogenic effects of hepatocyte growth factor and transforming growth factor-alpha in adult rat liver